Xuelei Wang

Oct 4, 2024 | dx.doi.org | Xuelei Wang |Xiaowei Wang |Dan Wang

Jul 7, 2024 | dovepress.com | Dan Wang |Xiaobo Wang |Xiaowei Wang |Xuelei Wang

Dan Wang,* Xiaobo Wang,* Yan Li, Xiaowei Wang, Xuelei Wang, Jiayi Su, Apeng Wang, Kai Lv, Mingliang Liu, Guimin Xia Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, People’s Republic of China *These authors contributed equally to this work Correspondence: Guimin Xia; Apeng Wang, Email [email protected]; [email protected] Background: Gemcitabine (Gem) is one of the first-line chemotherapy drugs for pancreatic...

May 29, 2024 | mdpi.com | Yan Lin |Xuelei Wang |JING YANG |Shutian Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 26, 2023 | mdpi.com | Jinfeng Yang |Xuelei Wang |Xinrong Li |Zhuang Tian

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.